Chemplast Sanmar Limited (NSE:CHEMPLASTS)
207.46
-7.06 (-3.29%)
Jun 3, 2026, 3:30 PM IST
Chemplast Sanmar Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 42,238 | 43,461 | 39,230 | 49,411 | 58,920 |
Other Revenue | 281.4 | - | - | - | - |
| 42,519 | 43,461 | 39,230 | 49,411 | 58,920 | |
Revenue Growth (YoY) | -2.17% | 10.79% | -20.61% | -16.14% | 55.10% |
Cost of Revenue | 26,735 | 27,529 | 27,082 | 32,117 | 37,150 |
Gross Profit | 15,784 | 15,932 | 12,148 | 17,294 | 21,770 |
Selling, General & Admin | 2,649 | 2,679 | 1,756 | 1,515 | 1,235 |
Other Operating Expenses | 10,875 | 10,713 | 9,780 | 10,423 | 7,903 |
Operating Expenses | 15,655 | 15,381 | 13,049 | 13,358 | 10,509 |
Operating Income | 129 | 550.4 | -901.2 | 3,936 | 11,261 |
Interest Expense | -2,354 | -1,283 | -867.2 | -722.6 | -2,394 |
Interest & Investment Income | - | 401.8 | 598.4 | 643.1 | 338.6 |
Currency Exchange Gain (Loss) | - | -314.6 | -337.9 | -527.7 | -631.8 |
Other Non Operating Income (Expenses) | - | -1,060 | -928.4 | -808.8 | -811.8 |
EBT Excluding Unusual Items | -2,225 | -1,705 | -2,436 | 2,520 | 7,762 |
Gain (Loss) on Sale of Assets | - | 13.9 | 180.6 | 0.2 | 193.2 |
Asset Writedown | - | - | - | -805 | - |
Other Unusual Items | -1,499 | - | - | - | - |
Pretax Income | -3,724 | -1,691 | -2,256 | 1,715 | 7,956 |
Income Tax Expense | -925.4 | -587.1 | -671.4 | 191.6 | 1,469 |
Net Income | -2,799 | -1,104 | -1,584 | 1,524 | 6,487 |
Net Income to Common | -2,799 | -1,104 | -1,584 | 1,524 | 6,487 |
Net Income Growth | - | - | - | -76.51% | 58.17% |
Shares Outstanding (Basic) | 158 | 158 | 158 | 158 | 149 |
Shares Outstanding (Diluted) | 158 | 158 | 158 | 158 | 149 |
Shares Change (YoY) | 0.01% | - | - | 6.43% | 10.80% |
EPS (Basic) | -17.70 | -6.98 | -10.02 | 9.64 | 43.66 |
EPS (Diluted) | -17.70 | -6.98 | -10.02 | 9.64 | 43.66 |
EPS Growth | - | - | - | -77.93% | 42.75% |
Free Cash Flow | -217.9 | -2,106 | -8,639 | -641.6 | 7,885 |
Free Cash Flow Per Share | -1.38 | -13.32 | -54.64 | -4.06 | 53.07 |
Gross Margin | 37.12% | 36.66% | 30.97% | 35.00% | 36.95% |
Operating Margin | 0.30% | 1.27% | -2.30% | 7.97% | 19.11% |
Profit Margin | -6.58% | -2.54% | -4.04% | 3.08% | 11.01% |
Free Cash Flow Margin | -0.51% | -4.84% | -22.02% | -1.30% | 13.38% |
EBITDA | 2,261 | 2,496 | 575.6 | 5,319 | 12,596 |
EBITDA Margin | 5.32% | 5.74% | 1.47% | 10.76% | 21.38% |
D&A For EBITDA | 2,132 | 1,946 | 1,477 | 1,383 | 1,335 |
EBIT | 129 | 550.4 | -901.2 | 3,936 | 11,261 |
EBIT Margin | 0.30% | 1.27% | -2.30% | 7.97% | 19.11% |
Effective Tax Rate | - | - | - | 11.17% | 18.46% |
Revenue as Reported | 42,519 | 43,931 | 40,035 | 50,210 | 59,495 |